Typical antipsychotics (sometimes referred to as first generation antipsychotics, conventional antipsychotics, classical neuroleptics, or major tranquilizers) are a class of
antipsychoticdrugs first developed in the 1950s and used to treat psychosis(in particular, schizophrenia), and are generally being replaced by atypical antipsychoticdrugs. Typical antipsychotics may also be used for the treatment of acute mania, agitation, and other conditions. The first typical antipsychotics to enter clinical use were the phenothiazines.
High-potency and low-potency
Traditional antipsychotics are classified as either "high-potency" or "low-potency":
Some of the high-potency antipsychotics have been formulated as the decanoate ester (e.g. fluphenazine decanoate) to allow for a slow release of the active drug when given as a deep, intramuscular injection. This has the advantage of providing reliable dosing for a person who doesn't want to be drugged. Depot injections can also be used for involuntary community treatment patients to ensure compliance with a community treatment order when the patient would refuse to take daily oral medication. Depot preparations were limited to high-potency antipsychotics so choice was limited. It is therefore preferable to use oral medications if the cooperation and compliance of the patient can be assured.
The oldest depots available were
haloperidoland fluphenazine, with flupentixoland zuclopenthixolas more recent additions. All have a similar, predominantly extrapyramidal, side effect profile though there are some variations between patients. More recently a long acting preparation of the atypical antipsychotic risperidonehas become available, offering a new choice. Risperidone still has a higher incidence of extrapyramidal effects than some other drugs available however.
Common side effects
Side effects vary among the various agents in this class of medications, but common side effects include: dry mouth,
musclestiffness, muscle cramping, tremors, EPS and weight-gain. EPS is a cluster of symptoms consisting of akathisia, parkinsonism, dystonias, Anticholinergics such as benztropineand diphenhydramineare commonly prescribed to treat the symptoms of EPS.
Risks of serious side effects
There is a significant risk of the serious condition
tardive dyskinesiadeveloping as a side effect of typical antipsychotics. The risk of developing tardive dyskinesia after chronic typical antipsychotic usage varies on several factors, such as age and gender. The commonly reported incidence of TD among younger patients is about 5% per year. Among older patients incidence rates as high as 20% per year have been reported. The average prevalence is approximately 30%. [cite journal |author=Llorca PM, Chereau I, Bayle FJ, Lancon C |title=Tardive dyskinesias and antipsychotics: a review |journal=Eur. Psychiatry |volume=17 |issue=3 |pages=129–38 |year=2002 |pmid=12052573|doi=10.1016/S0924-9338(02)00647-8] There are no treatments that have consistently been shown to be effective for the treatment of tardive dyskinesias, however branched chain amino acids, melatonin, and vitamin E have been suggested as possible treatments. The atypical antipsychotic clozapinehas also been suggested as an alternative antipsychotic for patients experiencing tardive dyskinesia. Tardive dyskinesia may reverse upon discontinuation of the offending agent or it may be irreversible. Neuroleptic malignant syndrome, or NMS, is a rare, but potentially fatal side effect of antipsychotic treatment. NMS is characterized by fever, muscle rigidity, autonomic dysfunction, and altered mental status. Treatment includes discontinuation of the offending agent and supportive care.
The role of typical antipsychotics has come into question recently as studies have suggested that atypical antipsychotics may increase the risk of death in elderly patients. A retrospective cohort study from the "New England Journal of Medicine" on Dec. 1, 2005 showed an increase in risk of death with the use of typical antipsychotics that was on par with the increase shown with atypical antipsychotics. [cite journal |author=Wang PS, Schneeweiss S, Avorn J, "et al" |title=Risk of death in elderly users of conventional vs. atypical antipsychotic medications |journal=N. Engl. J. Med. |volume=353 |issue=22 |pages=2335–41 |year=2005 |pmid=16319382 |doi=10.1056/NEJMoa052827] This has led some to question the common use of antipsychotics for the treatment of agitation in the elderly, particularly with the availability of alternatives such as mood stabilizing and antiepileptic drugs.
Prochlorperazine(Compazine, Buccastem, Stemetil)
Wikimedia Foundation. 2010.
Look at other dictionaries:
Antipsychotic — Advertisement for Thorazine (chlorpromazine) from the 1950s An antipsychotic (or neuroleptic) is a tranquilizing psychiatric medication primarily used to manage psychosis (including delusions or hallucinations, as well as disordered tho … Wikipedia
Atypical antipsychotic — The atypical antipsychotics (also known as second generation antipsychotics) are a group of antipsychotic drugs used to treat psychiatric conditions. Some atypical antipsychotics are FDA approved for use in the treatment of schizophrenia. Some… … Wikipedia
Chlorpromazine — Systematic (IUPAC) name … Wikipedia
Schizophrenia — MeshName = Schizophrenia MeshNumber = F03.700.750 Schizophrenia (pron en|ˌskɪtsəˈfriːniə), from the Greek roots schizein (σχίζειν, to split ) and phrēn , phren (φρήν, φρεν , mind ) is a psychiatric diagnosis that describes a mental disorder… … Wikipedia
Psychiatric medication — is a licenced psychoactive drug taken to exert an effect on the mental state and used to treat mental disorders. Usually utilized in psychiatric settings, these medications are made of synthetic chemical compounds, although some are naturally… … Wikipedia
Haloperidol — Systematic (IUPAC) name 4 [4 (4 chlorophe … Wikipedia
Perphenazine — Systematic (IUPAC) name 2 [4 [3 (2 chloro 10H phenothiazin 10 yl) propyl]piperazin 1 yl]ethanol Clinical data AHFS/Drugs.com … Wikipedia
Tardive dysphrenia — DiseaseDisorder infobox Name = Tardive dysphrenia ICD10 = ICD9 = ICD9|333.82 The medical expression Tardive Dysphrenia, was proposed by the American neurologist Stanley Fahn, the head of the Division of Movements Disorders of the Neurological… … Wikipedia
Treatment of schizophrenia — The concept of a cure as such in the treatment of schizophrenia remains controversial, as there is no consensus on the definition of treatment in the case of schizophrenia, although some criteria for the remission of symptoms have recently been… … Wikipedia
Cyamemazine — Systematic (IUPAC) name 10 (3 dimethylamino 2 methyl propyl)phenothiazine 2 carbonitrile Clinical data AHFS/Drugs.com … Wikipedia